Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionWayfinding Financial, LLC
Latest Disclosed Ownership4,898 shares
Latest Disclosed Value $ 502
Wayfinding Financial, LLC reports 10.46% decrease in ownership of ABL / Abbott Laboratories

On May 12, 2026 - Wayfinding Financial, LLC filed a 13F-HR form disclosing ownership of 4,898 shares of Abbott Laboratories (DE:ABL) valued at $435,040 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 5,470 shares of Abbott Laboratories. The current value of the position is $368,428 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBOTT LABORATORIES COM Common Stock 002824100 4,898 -572 -10.46 1 0.2180
2026-02-12 2025-12-31 13F ABBOTT LABS COM Stock 002824100 5,470 -175 -3.10 1 0.2900
2025-11-14 2025-09-30 13F ABBOTT LABS COM COM 002824100 5,645 -80 -1.40 1 0.3255
2025-08-12 2025-06-30 13F ABBOTT LABS COM COM 002824100 5,725 -392 -6.41 1 0.3323
2025-04-29 2025-03-31 13F ABBOTT LABS COM 002824100 6,117 -496 -7.50 1 0.3553
2025-02-11 2024-12-31 13F ABBOTT LABS COM 002824100 6,613 6,613 1 0.3999
2024-11-04 2024-09-30 13F ABBOTT LABS Stock 002824100 0 -5,778 -100.00 0 0.0000
2024-08-09 2024-06-30 13F ABBOTT LABS Stock 002824100 5,778 -488 -7.79 1 0.3377
2024-05-09 2024-03-31 13F ABBOTT LABS Stock 002824100 6,266 310 5.20 1 0.3843
2024-01-10 2023-12-31 13F ABBOTT LABS Stock 002824100 5,956 -74 -1.23 1 0.4458
2023-11-02 2023-09-30 13F ABBOTT LABS COM Stock 002824100 6,030 49 0.82 1 0.4363
2023-07-31 2023-06-30 13F ABBOTT LABS Stock 002824100 5,981 586 10.86 1 0.4681
2023-05-05 2023-03-31 13F ABBOTT LABS COM Stock 002824100 5,395 394 7.88 1 0.4151
2023-02-10 2022-12-31 13F ABBOTT LABS Stock 002824100 5,001 -509 -9.24 1 -100.00 0.4827
2022-11-09 2022-09-30 13F ABBOTT LABS Stock 002824100 5,510 663 13.68 533 1.33 0.4976
2022-08-09 2022-06-30 13F ABBOTT LABS Stock 002824100 4,847 -89 -1.80 526 -5.05 0.4621
2022-05-09 2022-03-31 13F ABBOTT LABS COM Stock 002824100 4,936 -65 -1.30 554 -7.97 0.4632
2022-01-28 2021-12-31 13F ABBOTT LABS Stock 002824100 5,001 5,001 602 0.4827
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.